Governance Classic Home
Sai Life Sciences LtdPharmaceuticalsINE570L01029Consolidated₹1600.95+53.95 (+3.49%)Jun-26
Valuation
Market Cap₹33.98K Cr
TTM PE93.21x
Forward PE91.21x
PEG27.66
Book Value₹117.00
P/B13.68x
TTM EPS₹17.17
Fwd EPS₹17.55
TTM Revenue₹2.25K Cr
TTM PAT₹361.75 Cr
TTM EBITDA₹658.26 Cr
TTM EBIT₹483.18 Cr
Last Qtr PAT₹73.29 Cr
Last Qtr EBITDA₹148.02 Cr
Last Qtr EBIT₹102.08 Cr
Profitability
ROE14.57%
ROCE18.68%
TTM NPM16.08%
TTM EBITDA %29.25%
Curr OPM13.14%
Last OPM16.88%
Curr NPM—
Last NPM—
Curr EPS₹3.46
Last EPS₹4.93
Balance sheet
Equity₹21.18 Cr
Reserve₹2.46K Cr
Total Debt₹288.45 Cr
D/E0.12x
Interest %10.42%
Curr Interest₹7.64 Cr
Price / range
Close₹1600.50
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+3.55%
1W+0.99%
1M+11.28%
3M+32.69%
6M+57.67%
1Y+78.99%
2Y—
3Y—
5Y—
Diwali+77.80%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue546.73+13.2%594.34549.18526.67483.042,153.23
Other Income3.5415.758.4514.9310.0149.13
Total Income550.27+11.6%610.09557.63541.60493.042,202.36
Interest5.986.168.067.7010.7032.62
Expenditure-454.94-9.6%-473.53-418.86-430.73-415.06-1,738.18
PBDT000000
EBITDA139.90+23.8%168.13178.98139.85113.01599.97
Depreciation-42.13-41.16-40.60-36.21-34.33-152.30
EBIT97.77+24.3%126.97138.38103.6478.68447.67
PBT95.33+22.2%136.85130.47110.8777.98456.17
Tax-24-34.32-32.84-27.92-19.61-114.69
Equity21.2321.1821.12020.8621.18
OPM17.3222.4323.4021.0515.8220.71
Net Profit71.34+22.2%102.5397.6382.9558.37341.48
NPM12.9616.8117.5115.7511.8415.51
EPS3.36+20.0%4.854.643.972.8016.27

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue2,153.23+31.1%1,642.05
Other Income49.1337.34
Total Income2,202.36+31.1%1,679.38
Expenditure-1,738.18-20.1%-1,447.67
Interest-32.62-70.03
PBDT00
EBITDA599.97+53.7%390.44
Depreciation-152.30-126.03
EBIT447.67+69.3%264.41
PBT456.17+96.9%231.72
Tax-114.69-58.25
Equity21.1820.84
OPM (%)20.7113.80
Net Profit341.48+96.9%173.46
NPM (%)15.5110.33
EPS (Rs)16.27+80.8%9
CEPS16.088.78

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue554.29+11.7%602.14556.46537.47496.422,192.49
Other Income3.5415.528.3815.339.9049.13
Total Income557.83+10.2%617.66564.84552.80506.322,241.62
Interest7.647.839.709.3512.3639.24
Expenditure-459.85-8.1%-478.72-422.39-440.74-425.58-1,767.43
PBDT000000
EBITDA148.02+22.4%176.56187.85145.83120.92631.16
Depreciation-45.94-45.31-44.08-39.75-37.72-166.86
EBIT102.08+22.7%131.25143.77106.0883.20464.30
PBT97.97+21.3%139.23134.17112.0580.75466.19
Tax-24.69-34.99-33.79-28.21-20.29-117.28
Equity21.2321.180020.8621.18
OPM17.5622.5423.7520.2715.9520.80
Net Profit73.29+21.2%104.24100.3883.8460.46348.91
NPM13.1416.8817.7715.1711.9415.57
EPS3.46+19.3%4.934.774.012.9016.63

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 2 years
MetricFY 25-26FY 24-25
Revenue2,192.49+29.4%1,694.57
Other Income49.1336.78
Total Income2,241.62+29.5%1,731.35
Expenditure-1,767.43-17.5%-1,503.65
Interest-39.24-76.16
PBDT00
EBITDA631.16+55.6%405.65
Depreciation-166.86-138.57
EBIT464.30+73.8%267.08
PBT466.19+104.7%227.70
Tax-117.28-57.57
Equity21.1820.84
OPM (%)20.8013.15
Net Profit348.91+105.1%170.13
NPM (%)15.579.83
EPS (Rs)16.63+88.3%8.83
CEPS16.438.61

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

0

No dividend history.

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers